MARLBOROUGH, Mass., May 16, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices….
May 16, 2017 at 10:28AM
from
No comments:
Post a Comment